Medivolve Inc. (MEDVF)
| Market Cap | 2.70K +9,907.4% |
| Revenue (ttm) | 666.14K -50.6% |
| Net Income | -10.69M |
| EPS | -0.40 |
| Shares Out | 27.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0020 |
| 52-Week Range | 0.000001 - 0.0001 |
| Beta | -46.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Medivolve
Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada. [Read more]
Financial Performance
In 2023, Medivolve's revenue was 686,451, a decrease of -50.56% compared to the previous year's 1.39 million. Losses were -16.46 million, -10.39% less than in 2022.
Financial numbers in CAD Financial StatementsNews
Medivolve Announces Management Changes
TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief...
Medivolve Announces Change of Auditor
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners...
Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors
TORONTO, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) is pleased to announce that it has entered into a master services agreement da...
Medivolve Announces Change of Auditor and Board Changes
TORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from McGovern Hurley LLP (“McGovern”) t...
Medivolve Announces Board Changes
TORONTO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) announces today that Dr. Beverley Richardson has resigned from its board of di...
Medivolve Announces Results of Annual and Special Shareholder Meeting
TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) reports that the nominees listed in the management information circular dated ...
Medivolve Achieves Significant Milestone by Establishing Management Services Organization
TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA: 4NC) is pleased to announce that it has established Medivolve Management Services, ...
Medivolve to Host Live Webinar to Discuss Corporate Update
TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA: 4NC) is pleased to announce that it will be hosting a corporate update presentatio...
Medivolve to Implement Share Consolidation
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA: 4NC) will consolidate its common shares on the basis of one new common share for e...